Linc AB Total Liabilities
Linc AB total liabilities. Based on the latest financial reports, Linc AB (LINC) has total liabilities worth Skr7.75 Million SEK (≈ $834.24K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Linc AB liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Linc AB (2018–2025)
Total liabilities of Linc AB from 2018 to 2025. This chart illustrates how Linc AB's total liabilities have evolved over time, based on quarterly financial data.
Linc AB Competitors by Total Liabilities
The table below lists competitors of Linc AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jinyuan Cement Co Ltd
SHE:000546
|
China | CN¥1.12 Billion |
|
Beijing Jingyeda Technology Co Ltd
SHE:003005
|
China | CN¥293.89 Million |
|
Anhui Transport Consulting &
SHG:603357
|
China | CN¥2.93 Billion |
|
BlueLinx Holdings Inc
NYSE:BXC
|
USA | $982.54 Million |
|
Three Stars NM
SHG:603578
|
China | CN¥3.75 Billion |
|
Oriental Times Media Corp
SHE:002175
|
China | CN¥177.20 Million |
|
Sampoerna Agro Tbk
JK:SGRO
|
Indonesia | Rp3.54 Trillion |
|
Sichuan Shengda Forestry Industry Co Ltd
SHE:002259
|
China | CN¥650.64 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Linc AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Linc AB.
Liquidity & Leverage Metrics
Linc AB Total Liabilities Ratios Explained
Linc AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 27.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.00 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Linc AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Linc AB (2018–2025)
The table below shows the annual total liabilities of Linc AB from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr11.62 Million ≈ $1.25 Million |
+32.69% |
| 2024-12-31 | Skr8.76 Million ≈ $942.39K |
+200.31% |
| 2023-12-31 | Skr2.92 Million ≈ $313.81K |
+2.42% |
| 2022-12-31 | Skr2.85 Million ≈ $306.38K |
-97.82% |
| 2021-12-31 | Skr130.48 Million ≈ $14.04 Million |
-9.49% |
| 2020-12-31 | Skr144.17 Million ≈ $15.51 Million |
+2731.78% |
| 2019-12-31 | Skr5.09 Million ≈ $547.87K |
+143.82% |
| 2018-12-31 | Skr2.09 Million ≈ $224.70K |
-- |
About Linc AB
Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and o… Read more